Search Results 221-230 of 16081 for pharmacogenetics
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first ...
Mayo Clinic Research Core Facilities: Molecular development cores produce monoclonal and polyclonal antibodies and transgenic and knockout mice.
See educational opportunities and alumni in Nilufer Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes lab at Mayo Clinic.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
The Vaccine Research Group at Mayo Clinic, led by Dr. Poland, Dr. Kennedy and Dr. Ovsyannikova researches vaccines, immunity and the threat of infectious ...
Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic is identifying novel mitophagy regulators and EOPD genes.
National Human Genome Research Institute: Polygenic risk scores. CanRisk breast and ovarian cancer risk calculator. Publications. The eMERGE Network recommends ...
While some would like to drape the mantle "The father of pharmacogenomics" on Richard Weinshilboum, M.D., the scientist parries: "The only thing that I'm father ...
The Center for Individualized Medicine's laboratory services offer resources, expertise and support to investigators at Mayo Clinic, at other research ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.